Stock listing
Duality Biotherapeutics, Inc.
Selected listing: A414LZ · LS · EUR · DE
Duality Biotherapeutics, Inc. (Lang & Schwarz: A414LZ), Health Technology. Latest release Sep 30, 2026: An announcement has just been published by the issuer…
- Ticker
- Lang & Schwarz: A414LZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Duality Biotherapeutics, Inc.
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
September 30, 2026
Next Day Disclosure Return
September 29, 2026
Next Day Disclosure Return
September 28, 2026
2026 INTERIM REPORT
September 28, 2026
DualityBio Announces China NMPA Acceptance of Biologics License Application Seeking Approval for Trastuzumab Pamirtecan for the Treatment of Unresectable or Metastatic HER2-Positive Adult Breast Cancer
April 9, 2026
Research Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. company profile
View the public company page for Duality Biotherapeutics, Inc. on 6ix.
Duality Biotherapeutics, Inc. news
Read company news and market updates connected to Duality Biotherapeutics, Inc..
Duality Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Duality Biotherapeutics, Inc..
Alternate listings
9606:HKEX
HK · HKD
Alternate listing for Duality Biotherapeutics, Inc.; the primary context on this page is A414LZ:LS.
A414LZ:LSX
DE · EUR
Alternate listing for Duality Biotherapeutics, Inc.; the primary context on this page is A414LZ:LS.
4ZB:DUS
DE · EUR
Alternate listing for Duality Biotherapeutics, Inc.; the primary context on this page is A414LZ:LS.
DUTBF:OTC
US · USD
Alternate listing for Duality Biotherapeutics, Inc.; the primary context on this page is A414LZ:LS.
4ZB:FWB
DE · EUR
Alternate listing for Duality Biotherapeutics, Inc.; the primary context on this page is A414LZ:LS.